Emerging Company Profile
Lenz: focused on an eye drop for age-related farsightedness
Emerging Company Profile: With Versant, RA Capital-backed $47M series A, Lenz eyes pivotal study for presbyopia program
With a Versant and RA Capital-backed $47 million series A round, Lenz eyes pivotal study for presbyopia program.
Jun 17, 2021 | 3:08 PM GMT
Lenz is well-financed to begin